Search
for
Sort by
Research 511–540 of 724
- Parallels between vertebrate cardiac and cutaneous wound healing and regeneration
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Current Status of PRP Manufacturing Requirements & European Regulatory Frameworks: Practical Tools for the Appropriate Implementation of PRP Therapies in Musculoskeletal Regenerative Medicine
- Colchicine in Managing Skin Conditions: A Systematic Review
- Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature
- Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model
- The anti-inflammatory and analgesic activities of 2Br-Crebanine and Stephanine from Stephania yunnanenses H. S.Lo
- Effectiveness of Platelet-Rich Plasma for Patients With Carpal Tunnel Syndrome: A Systematic Review and meta-Analysis of Current Evidence in Randomized Controlled Trials
- Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
- Mucocutaneous manifestations in children with human immunodeficiency virus infection
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects
- COVID-19 and hypopituitarism
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Transdifferentiation of Human Hair Follicle Mesenchymal Stem Cells into Red Blood Cells by OCT4
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Lithium: one drug, five complications
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece
- Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia
- Recent advances in the role of neuroregulation in skin wound healing
- Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus
- Satisfaction with control of systemic lupus erythematosus and lupus nephritis: physician and patient perspectives
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- The Future of Alopecia Treatment: Plant Extracts, Nanocarriers, and 3D Bioprinting in Focus
- Skin manifestations associated with systemic diseases – Part I